Lv1
40 积分 2024-11-27 加入
A cell-based FcRn-dependent recycling assay for predictive pharmacokinetic assessment of therapeutic antibodies
1天前
待确认
Phase I study of anticolon cancer humanized antibody A33
27天前
已关闭
AMG 509, A STEAP1 X CD3 BISPECIFIC XMAB® 2+1 IMMUNE THERAPY, EXHIBITS AVIDITY-DRIVEN BINDING AND PREFERENTIAL KILLING OF HIGH STEAP1- EXPRESSING PROSTATE AND EWING SARCOMA CANCER CELLS
1个月前
已完结
Development of PROTAC Degrader Drugs for Cancer
4个月前
已完结
皖公网安备34019202002308
